Literature DB >> 30589602

Identification of blaVIM-1 Gene in ST307 and ST661 Klebsiella pneumoniae Clones in Italy: Old Acquaintances for New Combinations.

Aurora Piazza1, Francesco Comandatore1, Francesca Romeri2, Matteo Brilli3, Barbara Dichirico2, Annalisa Ridolfo4, Carlo Antona5, Claudio Bandi1,3, Maria Rita Gismondo2, Sara Giordana Rimoldi2.   

Abstract

In the past years, the Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae sequence type 258 (ST258) became an important worldwide spread nosocomial pathogen. Recent evidence shows that the global epidemiology is changing, with the rise of new lineages. In this study we report the microbiological and genomic features of two VIM-1-producing K. pneumoniae isolates belonging to the emerging ST307. Two extensively drug-resistant K. pneumoniae strains, collected between May and June 2017, were confirmed as blaVIM positive by GeneXpert system. The whole-genome sequencing revealed that both KpV_S_1 and KpV_S_2 isolates harbored blaVIM-1 and blaCTX-M-15 genes, besides qnrS1 and qnrB1, strB, mphA, tetR, and tetA determinants. KpV_S_1 and KpV_S_2 isolates belonged to ST661 and ST307, respectively. Both STs have been recently reported as responsible of outbreaks in several European countries. The detection of blaVIM-1 gene in nonpredominant K. pneumoniae clones in a hospital setting should alert on the changing of the epidemiological situation in Italy, usually endemic reservoir of KPC enzyme.

Entities:  

Keywords:  IncN1; Italy; ST307

Mesh:

Substances:

Year:  2018        PMID: 30589602     DOI: 10.1089/mdr.2018.0327

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

Review 1.  Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.

Authors:  Gisele Peirano; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting.

Authors:  K A Strydom; L Chen; M M Kock; A C Stoltz; G Peirano; D B Nobrega; M Lowe; M M Ehlers; N M Mbelle; B N Kreiswirth; J D D Pitout
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

3.  Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy.

Authors:  Vittoria Mattioni Marchetti; Ibrahim Bitar; Mario Sarti; Elena Fogato; Erika Scaltriti; Chiara Bracchi; Jaroslav Hrabak; Stefano Pongolini; Roberta Migliavacca
Journal:  Diagnostics (Basel)       Date:  2021-01-06

4.  Dissemination of bla NDM- 1 Gene Among Several Klebsiella pneumoniae Sequence Types in Mexico Associated With Horizontal Transfer Mediated by IncF-Like Plasmids.

Authors:  José Eduardo Toledano-Tableros; Catalina Gayosso-Vázquez; Ma Dolores Jarillo-Quijada; José Luis Fernández-Vázquez; Rayo Morfin-Otero; Eduardo Rodríguez-Noriega; Silvia Giono-Cerezo; Gabriel Gutkind; José Di Conza; José Ignacio Santos-Preciado; María Dolores Alcántar-Curiel
Journal:  Front Microbiol       Date:  2021-03-25       Impact factor: 5.640

5.  Molecular epidemiology of carbapenem-resistance plasmids using publicly available sequences.

Authors:  Galen E Card; Brandon D Pickett; Perry G Ridge; Richard A Robison
Journal:  Genome       Date:  2019-09-06       Impact factor: 2.449

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.